The company maintains a manageable leverage profile with a debt-to-equity ratio of 0.82 as of 2026Q1, though the current ratio of 0.98 suggests a lean liquidity position that warrants monitoring.
| Total Current Assets | 5.79B | 5.7B | 5.53B | 6.14B | 5.88B | 4.93B | 4.59B |
| Cash & Short-Term Investments | 1.07B | 1.06B | 1.07B | 1.38B | 1.23B | 740M | 618M |
| Cash Only | 1.07B | 1.06B | 1.07B | 1.38B | 1.23B | 740M | 618M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 2.66B | 2.64B | 2.3B | 2.33B | 2.13B |
| Days Sales Outstanding | 31.46 | - | 62.8 | 62.39 | 56.08 | 56.52 | 53.74 |
| Inventory | 1.67B | 1.67B | 1.59B | 1.85B | 2.23B | 1.7B | 1.69B |
| Days Inventory Outstanding | 99.05 | 96.03 | 89.4 | 99.34 | 121.9 | 93.63 | 92.92 |
| Other Current Assets | 3.05B | 2.97B | 205M | 265M | 123M | 154M | 162M |
| Total Non-Current Assets | 21.06B | 21.38B | 20.08B | 21.71B | 21.44B | 23B | 24.58B |
| Property, Plant & Equipment | 2.21B | 2.21B | 1.85B | 2.04B | 1.82B | 1.83B | 1.96B |
| Fixed Asset Turnover | 7.15x | 6.84x | 8.36x | 7.56x | 8.21x | 8.24x | 7.39x |
| Goodwill | 9.38B | 9.51B | 8.84B | 9.27B | 9.19B | 9.81B | 10.33B |
| Intangible Assets | 8.54B | 8.69B | 8.47B | 9.62B | 9.85B | 10.7B | 11.61B |
| Long-Term Investments | 1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 703M | 727M | 726M | 623M | 434M | 475M | 496M |
| Total Assets | 26.85B | 27.08B | 25.6B | 27.85B | 27.32B | 27.93B | 29.18B |
| Asset Turnover | 0.56x | 0.56x | 0.60x | 0.55x | 0.55x | 0.54x | 0.50x |
| Asset Growth % | 11.84% | 5.76% | -8.08% | 1.96% | -2.19% | -4.28% | - |
| Total Current Liabilities | 5.9B | 5.95B | 5.74B | 5.48B | 3.93B | 4.04B | 7.49B |
| Accounts Payable | 2.53B | 2.47B | 2.25B | 2.49B | 1.83B | 1.83B | 1.58B |
| Days Payables Outstanding | 143.01 | 142.55 | 126.65 | 133.58 | 100.16 | 100.51 | 87.07 |
| Short-Term Debt | 1.59B | 1.45B | 1.55B | 599M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.77B | 2.02B | 325M | 406M | 272M | 266M | 252M |
| Current Ratio | 0.98x | 0.96x | 0.96x | 1.12x | 1.50x | 1.22x | 0.61x |
| Quick Ratio | 0.70x | 0.68x | 0.69x | 0.78x | 0.93x | 0.80x | 0.39x |
| Cash Conversion Cycle | -12.5 | - | 25.54 | 28.15 | 77.82 | 49.64 | 59.58 |
| Total Non-Current Liabilities | 10.35B | 10.37B | 10.19B | 11.16B | 3.42B | 3.49B | 3.33B |
| Long-Term Debt | 7.07B | 7.07B | 6.94B | 7.69B | 8.93B | 0 | 0 |
| Capital Lease Obligations | 194M | 0 | 189M | 97M | 81M | 82M | 0 |
| Deferred Tax Liabilities | 9.51B | 2.35B | 2.26B | 2.62B | 2.48B | 2.43B | 1.76B |
| Other Non-Current Liabilities | 924M | 941M | 802M | 754M | -8.07B | 976M | 1.57B |
| Total Liabilities | 16.25B | 16.31B | 15.93B | 16.64B | 7.35B | 7.53B | 10.82B |
| Total Debt | 8.66B | 8.52B | 8.72B | 8.43B | 9.05B | 129M | 0 |
| Net Debt | 7.59B | 7.46B | 7.65B | 7.04B | 7.82B | -611M | -618M |
| Debt / Equity | 0.82x | 0.79x | 0.90x | 0.75x | 0.45x | 0.01x | - |
| Debt / EBITDA | 2.43x | 2.61x | 3.54x | 2.68x | 2.73x | 0.04x | - |
| Net Debt / EBITDA | 2.13x | 2.29x | 3.11x | 2.24x | 2.35x | -0.17x | - |
| Interest Coverage | 6.85x | 6.27x | 4.28x | 7.12x | - | - | - |
| Total Equity | 10.61B | 10.77B | 9.67B | 11.21B | 19.97B | 20.4B | 18.36B |
| Equity Growth % | 22.2% | 11.35% | -13.76% | -43.86% | -2.1% | 11.13% | - |
| Book Value per Share | 5.52 | 5.60 | 5.03 | 5.85 | 10.43 | 10.80 | 9.72 |
| Total Shareholders' Equity | 10.61B | 10.77B | 9.67B | 11.21B | 19.97B | 20.4B | 18.36B |
| Common Stock | 19M | 19M | 19M | 19M | 0 | 0 | 0 |
| Retained Earnings | -128M | -204M | -93M | 429M | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | -242M | -7M | 0 | 0 | 0 |
| Accumulated OCI | -5.21B | -4.96B | -6.15B | -5.38B | -5.46B | -4.47B | -3.57B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Post-separation cost structure volatility
According to recent financial filings, Kenvue's total assets have remained relatively stable at approximately $26.9 billion as of 2026Q1, suggesting that the company is successfully transitioning toward a steady-state balance sheet following the initial volatility associated with its spin-off from Johnson & Johnson.
The stabilization of total assets indicates that the company has largely completed its initial asset realignment. Investors should monitor whether this plateau in asset growth reflects a disciplined approach to capital allocation or a potential lack of aggressive reinvestment in its core consumer health portfolio.
As reported in quarterly statements, Kenvue's debt-to-equity ratio has fluctuated between 0.75 and 0.90 over the last ten quarters, with total debt standing at $8.7 billion in 2026Q1, reflecting a strategic effort to maintain a manageable leverage profile while navigating its new independent status.
The current debt levels appear to be a function of the initial capital structure established at the time of the spin-off. While the leverage ratio is currently within a reasonable range for a consumer defensive firm, the company's ability to deleverage will likely depend on its capacity to generate consistent free cash flow.
Based on the provided data, Kenvue's current ratio has hovered near 0.98 as of 2026Q1, which suggests that the company maintains a relatively lean liquidity position that warrants further investigation regarding its ability to absorb unexpected operational shocks or sudden shifts in working capital requirements.
A current ratio consistently below 1.0 indicates that the company relies heavily on its ongoing cash generation to meet short-term obligations. This tight liquidity profile may limit the company's flexibility to pursue opportunistic acquisitions or respond to aggressive competitive pricing actions in the short term.
As indicated by the company's financial statements, retained earnings have shifted from a positive $429 million in 2023Q4 to a deficit of $128 million by 2026Q1, highlighting the impact of separation-related costs and ongoing adjustments to the company's independent equity base.
The erosion of retained earnings suggests that the company is absorbing significant non-recurring costs associated with its standalone operations. Investors should look for a reversal of this trend as a key indicator that the company has successfully moved past its initial post-spin-off restructuring phase.
Quick answers to the most common questions about buying KVUE stock.
As of 2025, Kenvue Inc. (KVUE) had total assets of $27.08B including $5.70B in current assets.
Kenvue Inc. (KVUE) carries total debt of $8.52B, offset by $1.06B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Kenvue Inc. (KVUE) has total shareholders' equity (book value) of $10.77B ($5.60 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Kenvue Inc. (KVUE) reported a current ratio of 0.96x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.